A role for fibroblast growth factor 19 and bile acids in diabetes remission after Roux-en-Y gastric bypass

Authors :: Gerhard, Glenn S.
Styer, Amanda M.
Wood, G. Craig
Roesch, Stephen L.
Petrick, Anthony T.
Gabrielsen, Jon
Strodel, William E.
Still, Christopher D.
Argyropoulos, George
Source :: Diabetes Care. July, 2013, Vol. 36 Issue 7, p1859, 6 p.
Publication Year :: 2013
Abstract: OBJECTIVE--Roux-en-Y gastric bypass (RYGB) in humans can remit type 2 diabetes, but the operative mechanism is not completely understood. In mice, fibroblast growth factor (FGF) 15 (FGF19 in humans) regulates [...]

Subjects :: Gastric bypass -- Complications and side effects -- Patient outcomes -- Research
Type 2 diabetes -- Risk factors -- Care and treatment -- Research
Fibroblast growth factors -- Physiological aspects -- Research
Health

Full Text Access

Tools